Supplier
Orsini Pharmaceutical Services, LLC
Orsini Pharmaceutical Services, LLC was paid $187.47M by Medicaid between Jan 2018 and Nov 2024, across 12 billing codes. Its largest line is J1428, Injection, eteplirsen, 10 mg — 49% of everything it billed.
33Billing provider infoORSINI PHARMACEUTICAL SERVICES, LLC
ELK GROVE VILLAGE, IL 60007
ELK GROVE VILLAGE, IL 60007
33aNPI1073608998assigned 10/04/2006
33bProvider typePharmacy
28Total paid$187.47M
24GClaims29,739
24DCodes billed12
24AFirst – last monthJan 2018 – Nov 2024
Compared with peers
Next to other Pharmacy providers in Illinois
Rank by total paid#1 of 10
Median peer was paid$2K
This provider vs. median82,077×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 891 | $655K | |
| 2019 | 2,574 | $5.30M | |
| 2020 | 4,134 | $4.61M | |
| 2021 | 5,407 | $22.53M | |
| 2022 | 6,732 | $49.11M | |
| 2023 | 6,364 | $59.38M | |
| 2024incomplete | 3,637 | $45.88M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| J1428 | Injection, eteplirsen, 10 mg | 49% | 4,411 | 915 | $92.29M |
| J1426 | Injection, casimersen, 10 mg | 35% | 2,062 | 747 | $65.64M |
| J0584 | Injection, burosumab-twza 1 mg | 5.3% | 510 | 320 | $9.85M |
| J2315 | Injection, naltrexone, depot form, 1 mg | 4.9% | 7,728 | 6,913 | $9.20M |
| Q9992 | Injection, buprenorphine extended-release (sublocade), greater than 100 mg | 2.5% | 3,261 | 2,505 | $4.69M |
| Q9991 | Injection, buprenorphine extended-release (sublocade), less than or equal to 100 mg | 2.0% | 2,657 | 2,022 | $3.72M |
| J3490 | Unclassified drugs | <1% | 26 | 14 | $921K |
| 99602 | Nursing care in home rn | <1% | 2,343 | 659 | $428K |
| 99601 | <1% | 4,040 | 1,259 | $413K | |
| S9379 | Home infusion therapy, infusion therapy, not otherwise classified; administrative services, professional pharmacy services, care coordination, and all necessary supplies and equipment (drugs and nursing visits coded separately), per diem | <1% | 2,331 | 784 | $186K |
| J3032 | Injection, eptinezumab-jjmr, 1 mg | <1% | 57 | 56 | $123K |
| A4222 | Infusion supplies for external drug infusion pump, per cassette or bag (list drugs separately) | <1% | 313 | 92 | $7K |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialTOM, BRANDON (PRESIDENT AND CEO)